Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer.
Npj Precision Oncology
Medford, Arielle J AJ; Dubash, Taronish D TD; Juric, Dejan D; Spring, Laura L; Niemierko, Andrzej A; Vidula, Neelima N; Peppercorn, Jeffrey J; Isakoff, Steven S; Reeves, Brittany A BA; LiCausi, Joseph A JA; Wesley, Benjamin B; Malvarosa, Giuliana G; Yuen, Megan M; Wittner, Ben S BS; Lawrence, Michael S MS; Iafrate, A John AJ; Ellisen, Leif L; Moy, Beverly B; Toner, Mehmet M; Maheswaran, Shyamala S; Haber, Daniel A DA; Bardia, Aditya A
Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma.
The Oncologist
Ikeda, Sadakatsu S; Tsigelny, Igor F IF; Skjevik, Åge A ÅA; Kono, Yuko Y; Mendler, Michel M; Kuo, Alexander A; Sicklick, Jason K JK; Heestand, Gregory G; Banks, Kimberly C KC; Talasaz, AmirAli A; Lanman, Richard B RB; Lippman, Scott S; Kurzrock, Razelle R